- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03196687
Frequency of Asymptomatic Left Ventricular Diastolic Dysfunction in Diabetes Mellitus Type 2
Patients with type 2 DM may develop a cardiomyopathy often called diabetic cardiomyopathy which is characterized by left ventricular diastolic dysfunction in early stages
Type 2 DM is associated with various types of subclinical target organ damage resulting in elevated risk of CVD events, moreover there is growing evidence that a prediabetic status, such as impaired fasting glucose is also related to subclinical target organ damage when compared to a group with normal glucose metabolism Diabetes mellitus is a well-studied major risk factor for coronary heart diseases, which is one of the leading causes of death worldwide. Another distinct entity of diabetes-related cardiac affection is the diabetic cardiomyopathy. This entity of cardic affection by diabetes still needs more and more attention, not only because it is common in diabetic patients, but also because of its easy detection by the simple, inexpensive and widely available diagnostic echocardiography.
Study Overview
Status
Conditions
Detailed Description
Patients with type 2 DM may develop a cardiomyopathy often called diabetic cardiomyopathy which is characterized by left ventricular diastolic dysfunction in early stages
Type 2 DM is associated with various types of subclinical target organ damage resulting in elevated risk of CVD events, moreover there is growing evidence that a prediabetic status, such as impaired fasting glucose is also related to subclinical target organ damage when compared to a group with normal glucose metabolism
Diabetes mellitus is a well-studied major risk factor for coronary heart diseases, which is one of the leading causes of death worldwide. Another distinct entity of diabetes-related cardiac affection is the diabetic cardiomyopathy. This entity of cardic affection by diabetes still needs more and more attention, not only because it is common in diabetic patients, but also because of its easy detection by the simple, inexpensive and widely available diagnostic echocardiography.
The proposed mechanisms that may be implicated in the pathogenesis of diabetic cardiomyopathy include autonomic dysfunction, microvascular disease, interstitial fibrosis and metabolic disorders. However, the actual causes and mechanisms remain unclear.
Study Type
Enrollment (Anticipated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- DM type 2 who are asymptomatic of any cardiac symptom.
Exclusion Criteria:
- Patients of known hypertension with or without treatment.
- Cardiac arrhythmias.
- Cardiomyopathy.
- Valvular heart disease.
- Heart failure.
- Chronic pulmonary disease.
- Extreme age.
- Chronic renal failure.
- Subjects with poor transthoracic echo window.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
percentage of Frequency of asymptomatic left ventricular diastolic dysfunction in diabetes mellitus type 2
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- assiut university9000
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diastolic Dysfunction
-
Clinica ARS MedicaUnknown
-
University of Colorado, DenverUniversity of Colorado Nutrition Obesity Research Center (NORC)Active, not recruitingDiastolic DysfunctionUnited States
-
South Egypt Cancer InstituteCompletedDiastolic DysfunctionEgypt
-
Brigham and Women's HospitalTerminatedDiastolic DysfunctionUnited States
-
Newcastle-upon-Tyne Hospitals NHS TrustUnknown
-
Imperial College LondonRecruitingDiastolic DysfunctionUnited Kingdom
-
Yan Zhou, MDCompletedDiastolic DysfunctionChina
-
University of Missouri-ColumbiaKansas City Veteran Affairs Medical CenterCompletedDiastolic DysfunctionUnited States
-
University College, LondonUnknownDiastolic Dysfunction
-
Texas Tech University Health Sciences CenterRecruitingDiastolic Heart Failure | Diastolic Dysfunction | Systolic DysfunctionUnited States